PGEN Earnings

PGEN reported its earnings on 2026-03-25, showcasing a revenue of 4.57M against an estimate of 5.53M, resulting in a -17.45% surprise. The EPS was -0.01, surpassing the expected -0.09 by 88.89%. The stock experienced a 25.48% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following PGEN's earnings announcement on 2026-03-25, the stock price moved by 25.48% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, PGEN's stock price tends to shift by an average of 7.44% in the 10 days leading up to earnings and 3.86% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate PGEN's annual revenue to reach 21.20M, while the EPS is projected at -0.07. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between PGEN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, PGEN's stock price typically moves by 7.44% in the 10 days before its earnings and 3.86% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.07 and revenue of 21.20M.

The earnings call highlights strong financial performance with a 149% revenue increase, despite a net loss due to non-recurring items. The Q&A reveals positive progress in patient conversion and treatment completion, and management's optimism about the European market. The J-code is expected to enhance patient processing, and the revenue guidance is clear. While there is uncertainty about European approval timing, the overall sentiment is positive, driven by strong revenue growth and operational improvements.